Go back

Inside out

Back page gossip from the 21 May issue of Research Europe

Transparency of a sort

In April the European Commission admitted it made a “justified exception” to its lobbying rules when its president Ursula von der Leyen and R&D commissioner Mariya Gabriel spoke to the German vaccine company CureVac before the company had entered itself into the EU’s Transparency Register.

This article is only available to *Research Professional subscribers. If you are a subscriber you can read the article in full on researchprofessional.com